Loperamide Hydrochloride Capsule
NDC Package 60468-005-01
Package Information
Loperamide Hydrochloride capsules is (loperamide hydrochloride) is indicated for the control and symptomatic relief of acute nonspecific diarrhea in patients 2 years of age and older and of chronic diarrhea in adults associated with inflammatory bowel disease. This formulation utilizes a capsule delivery system. Marketed by Allphamed Pharbil Arzneimittel Gmbh, this product is identified by NDC 60468-005 and is authorized under FDA application ANDA215001.
Identification & Billing
- RxCUI: 978006 - loperamide HCl 2 MG Oral Capsule
- RxCUI: 978006 - loperamide hydrochloride 2 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60468 - Allphamed Pharbil Arzneimittel Gmbh
- 60468-005 - Loperamide Hydrochloride
- 60468-005-01 - 100 CAPSULE in 1 BOTTLE
- 60468-005 - Loperamide Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (60468-005). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60468-005-01 identifies a specific commercial package of 100 capsule in 1 bottle of Loperamide Hydrochloride, a human prescription drug labeled by Allphamed Pharbil Arzneimittel Gmbh. This capsule is formulated for oral use and contains loperamide hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Allphamed Pharbil Arzneimittel Gmbh on September 25, 2020. The current certification is valid through December 31, 2026.
How is this Allphamed Pharbil Arzneimittel Gmbh product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60468000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.